Administering apparatus comprising a dosage display
Claim Score by NHIP
Abstract
An administering apparatus with a dosage display, including a casing, a reservoir for a fluid product, a driven device which acts on the product, a dosing means for selecting a product dosage to be delivered which includes a dosage scale including a number of dosage marks axially spaced from each other, and a drive device coupled to the driven device for driving the driven device, the drive device performing a delivery stroke from an initial position, in a drive direction, to a delivery stopper, the length of the delivery stroke counter to the drive direction being limited by selecting the product dosage using the dosing means, wherein the casing is transparent at least in an area overlapping the dosage scale, and wherein the drive device forms an indicator to the dosage scale in order to indicate the initial position of the drive device.

Term
Term ended
Projected expiry passed 17 July 2023, 3.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
19 claims: 2 independent, 17 dependent
- 1An administering apparatus with a dosage display, comprising:a) a casing comprising a reservoir for a fluid product;b) a driven device which acts on said product contained in said reservoir, in order to deliver product;c) a dosing means, using which a product dosage to be delivered can be selected, and which comprises a dosage scale with a number of dosage marks axially spaced out from each other;and d) a drive device coupled to said driven device for driving the driven device, said drive device performing a delivery stroke from an initial position, in a drive direction, up to a delivery stopper, the length of said delivery stroke counter to the drive direction being limited by selecting the product dosage by means of said dosing means;e) wherein said casing is transparent, at least in an area overlapping said dosage scale;and wherein f) the drive device forms an indicator of the dosage scale, in order to indicate the initial position of the drive device in the transparent area of the casing, relative to said dosage marks.
- 18Broadest claimClaim Score 73, broad(NHIP)An administering apparatus with a dosage display, comprising a casing, a reservoir for a fluid product, a driven device which acts on the product, a dosing means for selecting a product dosage to be delivered comprising a dosage scale comprising a number of dosage marks axially spaced from each other, and a drive device coupled to the driven device for driving the driven device, wherein the casing is transparent at least in an area overlapping the dosage scale, and wherein the drive device forms an indicator relative to the dosage scale to indicate the initial position of the drive device.
Independent claims2
76 paragraphs in 5 sections, as filed
CROSS-REFERENCE TO RELATED APPLICATION
0001This application claims priority of German Patent Application No. 102 32 410.7, filed on Jul. 17, 2002.
BACKGROUND
0002The invention relates to administering devices and methods. More particularly, it relates to an administering apparatus or device with a dosage display which allows a product dosage to be selected, and to a method of providing a dosage display. The administering device of the present invention may be used in medical, veterinary, therapeutic, diagnostic, pharmaceutical and/or cosmetic applications. One preferred example of administering apparatus in accordance with the present invention is injection apparatus, including injection pens. Other examples of administering apparatus according to the invention can include inhalation apparatus or apparatus for administering liquid nutrients in doses.
0003Administering apparatus which allow a dosage to be selected naturally have a dosage display in order to indicate the selected product dosage to be administered to the user of the apparatus. A reliable dosage display is essential for selecting and administering the desired product dosage.
0004In the injection apparatus known from U.S. Pat. No. 6,628,067 B1, an optical dosage display is provided between two casing sleeves which can be rotated relative to each other, for selecting a dosage. The two casing sleeves overlap each other. A dosage scale is printed onto the inner casing sleeve in the overlapping area, the scale consisting of a sequence of dosage numbers representing dosage units. The outer casing sleeve in the overlapping area is transparent in the area of the dosage scale, by comprising an opening there which serves as a viewing window. To select a dosage, the two casing sleeves are rotated relative to each other. The injection apparatus further comprises a dosing sleeve arranged in the overlapping area between the two casing sleeves which is axially moved relative to the casing sleeves, to select the dosage. The dosing sleeve likewise comprises a viewing window for reading the dosage scale. The dosage scale is read through the two superimposed viewing windows of the dosing sleeve and the outer casing sleeve.
0005The selected product dosage can indeed be reliably read with the aid of this dosage scale. However, the user then only knows that he has selected the desired dosage. It remains uncertain whether the entire dosage or only a part of it, for example because evacuation of a product reservoir is already in progress, can be administered in the next injection.
SUMMARY
0006It is one object of the invention to provide a dosage display which gives reliable information about a product dosage which can actually be administered.
0007In one embodiment, the present invention comprises an administering apparatus with a dosage display, including a casing, a reservoir for a fluid product, a driven device which acts on the product, a dosing means for selecting a product dosage to be delivered comprising a dosage scale comprising a number of dosage marks axially spaced from each other, and a drive device coupled to the driven device for driving the driven device, wherein the casing is transparent at least in an area overlapping the dosage scale, and wherein the drive device forms an indicator relative to the dosage scale to indicate the initial position of the drive device.
0008The invention relates to a dosage display of an administering apparatus. In one embodiments, the administering apparatus comprises a casing which accommodates a reservoir for a fluid product or forms said reservoir itself. A product container which is accommodated in the casing, for example, an ampoule, can form the reservoir. A conveying device of the administering apparatus, mounted by the casing, comprises a driven device and a drive device which are coupled to each other in order to deliver product out of the reservoir, i.e., to convey product out of the reservoir through an outlet of the reservoir, to be administered. The driven device acts on the product, and is driven for this purpose by the drive device.
0009The administering apparatus further comprises a dosing means, using which a product dosage to be delivered can be selected. The drive device can be moved from an initial position in a drive direction up to a delivery stopper which is formed by the casing or can at least be fixed such that it cannot move relative to the casing with respect to the drive direction. The length, measured in the drive direction, of this delivery stroke of the drive device is set by selecting the product dosage by means of the dosing means. The delivery stroke is preferably a linear translational movement, but can in principle also be performed along a curved arc and can also be or comprise a rotational movement.
0010The dosing means comprises a dosage scale having a number of dosage marks for optically displaying dosage units. Preferably, in one embodiment, each product dosage, measured in dosage units, which can be selected is precisely allocated one dosage mark from the number of dosage marks. The dosage marks are spaced out from each other in the drive direction, such that each dosage mark from the number of dosage marks assumes a different height with respect to the drive direction, preferably an axial line corresponding to the drive direction.
0011The casing is transparent, at least in an area which overlaps the dosage scale. When it is mentioned in this context that the transparent area overlaps the dosage scale, then “overlap” is intended merely to mean that the dosage scale can be read in the transparent area of the casing. This can be achieved by providing the casing with an opening through which the dosage scale can be entirely or only partially read. More preferably, however, in one embodiment, the casing itself is a support for the dosage scale in the transparent area, for example by printing the dosage scale on an inner or outer surface of said area of the casing consisting of transparent material or forming it in the transparent casing material. Thus, the dosing scale can be produced in a transparent casing material of suitable material composition by means of laser irradiation. It is sufficient for the purposes of the invention if the casing is only transparent in the area overlapping the dosage scale. The casing may, however, also be completely transparent.
0012According to the invention, the drive device forms an indicator of the dosage scale whose axial position relative to the dosage scale can be read due to the transparency of the casing, in order to display the sited initial position of the drive device through the casing, relative to the dosage marks spaced out in the drive direction. The dosage scale is therefore a length scale extending in the drive direction, whose length units are the dosage marks spaced out in the drive direction. By reading, i.e., comparing, the position of the indicator of the drive device on this length scale, the user knows what delivery stroke the drive device will perform when the drive device is moved from its initial position in the drive direction up to the delivery stopper. Precisely when the drive device assumes a front end position in which it abuts the delivery stopper, the indicator of the drive device assumes the zero position on the dosage scale corresponding to a zero dosage.
0013In one preferred embodiment, the dosage marks spaced out in the drive direction are bar marks, each of said dosage marks formed by precisely one bar mark which extends over a particular length perpendicular to the drive direction and is advantageously as fine as possible. The indicator formed by the drive device is preferably also a bar or comprises a bar which points parallel to the bar marks. In principle, the indicator of the drive device can also be arrow-shaped or can exhibit a different shape suitable for an indicator, said shape enabling the position of the drive device on the dosage scale as compared to the dosage marks to be reliably identified.
0014In one preferred embodiment, the dosage scale additionally comprises dosage symbols which each represent a particular dosage, each of the symbols representing a different dosage. These dosage symbols, which are preferably dosage numbers corresponding directly to the dosage units, can also simultaneously form the spaced out dosage marks, by being appropriately shaped. Preferably, however, the dosage marks in accordance with the invention are provided in addition to such dosage symbols. In one embodiment, each of the dosage marks is allocated a dosage symbol in its immediate vicinity, such that the user can not only read the exact position of the display device, measured in the drive direction, on the dosage scale, but simultaneously also the dosage corresponding to this position, symbolically or directly in the form of a dosage number.
0015In one embodiment, the dosing means also comprises a dosage scale for optically displaying the product dosage selected. In one embodiment, the dosage scale on which the position of the drive device can be read also simultaneously forms the dosage scale for displaying the product dosage selected. In principle, however, it would also be conceivable to provide a separate dosage scale for each of these two dosage displays. In combination, the two integrated or independent dosage displays provide a display of the remaining amount. If, namely, a product dosage is selected which exceeds a remaining dosage still available in the reservoir, then comparing the dosage displays provides the user with a reliable indication that the selected product dosage can no longer actually be delivered or has not actually been delivered. Which of these two pieces of information the user receives depends on the type of coupling between the driven device and the drive device. In one case, the drive device cannot be moved up to the delivery stopper, such that the dosage display in accordance with the invention displays this state after administering. In one preferred embodiment, the drive device can only be moved relative to the driven device, opposite or counter to the drive direction, by a path length which corresponds to the remaining dosage still left in the reservoir. In this case, the user can directly read the remaining dosage left before delivery and, by comparing it with the display of the product dosage selected, determine the missing dosage. In this preferred variant of the coupling between the driven device and the drive device, the driven device forms a reverse stopper, which is the maximum to which the drive device can be moved counter to the drive direction, relative to the driven device.
0016For selecting the product dosage, the dosing means comprises a dosing member which forms the dosing stopper for the drive device. In one embodiment, the drive device can be moved counter to the drive direction up to said dosing stopper. A slight distance between the delivery stopper and the dosing stopper, as viewed in the drive direction, corresponds to the delivery stroke of the drive device, wherein however a deduction is to be made for the formation of a front and a rear stopper area of the drive device, measured in the drive direction.
0017The dosage scale for displaying the product dosage selected can be connected to the dosing member. In one preferred embodiment, however, it is connected to the casing, in particular when the same dosage scale also forms the display for the position of the drive device. If the dosage scale is connected to the casing, the dosing member forms an indicator whose position relative to said dosage scale indicates the product dosage selected. The indicator of the dosing member is formed by a viewing window, which may, in one embodiment, be developed into a magnifier.
0018Operational comfort is accommodated if the product dosage selected and the position of the drive device measured in the drive direction can be read in one glance, i.e., simultaneously. Expediently, the position of the drive device and the product dosage selected can be read alongside each other in the drive direction, providing the position of the drive device does not already exactly correspond to the product dosage selected. In one embodiment, if the product dosage selected is delivered from the initial position of the drive device by the delivery stroke, the indicator of the drive device and the indicator for displaying the product dosage selected overlap.
0019In one preferred embodiment, the dosing member can be moved translationally in the drive direction and/or counter to the drive direction, to adjust the dosing stopper. Its dosing movement is a combination of the translational movement and a rotational movement about the translational axis. In principle, however, the dosing movement of the dosing member could also be a purely translational or purely rotational movement. For one preferred embodiment of the combined rotational and translational movement, the dosing member is coupled to the casing via a swivel joint, preferably a screw joint, such that the rotational movement of the dosing member causes its translational movement.
0020If the dosing movement of the dosing member is a combined rotational and translational movement, wherein the rotational axis corresponds to the translational axis, then the dosage scale for displaying the product dosage selected is advantageously a sequence of dosage symbols, e.g., dosage numbers, running spirally around the rotational axis. As already explained, the same dosage scale can also form the dosage scale for displaying the position of the drive device, by allocating its dosage marks to the dosage symbols or by realizing them using the dosage symbols themselves, by appropriately representing them. In one embodiment, it is particularly advantageous if the indicator of the drive device extends circumferentially around the rotational axis of the dosing member, for example as a fine, intermittent or preferably continuous line, such that the indicator of the drive device can be read on the dosage scale in any rotational angular position of the dosing member.
0021In one preferred embodiment, the dosing member comprises an inner dosing body and an outer dosing body, between which a slight gap remains in an overlapping area. The inner dosing body protrudes into the casing. The casing protrudes into the slight gap. The outer dosing body can in particular form a gripping part of the dosing member. The dosing bodies are preferably arranged such that the dosing member can be rotated relative to the casing engaging with the gap. The nested arrangement of an inner dosing body and an outer dosing body allows the dosing member to be designed axially short. By producing the two dosing bodies separately, the dosing member can be more simply equipped than in the case of producing them as one piece having a higher functionality. If produced separately, the inner dosing body and the outer dosing body may be suitably connected to each other such that a translational movement between the dosing bodies along a translational axis and a rotational movement about the translational axis are not possible, but rather one dosing body slaves the other.
0022In one embodiment, the driven device preferably comprises a piston which is accommodated in the reservoir such that it can axially move in an advancing direction towards an outlet of the reservoir, in order to deliver product from the reservoir. In this embodiment, the driven device also comprises a piston rod. The driven device directly engages with the piston rod. The piston rod can be formed together with the piston as one piece or can be fixedly connected to the piston, for example by means of a screw connection or a fixed plug connection. In one preferred embodiment, however, the piston rod is formed as a separate part from the piston, said part pressing against the piston to deliver the product in the advancing direction. If the product is conveyed by means of a piston, then the advancing direction of the piston and the drive direction correspond.
0023In one embodiment, the driven device is coupled to the piston rod such that it slaves the piston rod when moved in the drive direction, but performs a movement counter to the drive direction without the piston rod. The piston rod and the driven device can be coupled via one or more transfer members. In one preferred embodiment, the piston rod and the driven device directly engage, causing the piston rod to be slaved. The engagement is releasable, in order to enable the reverse movement of the drive device, relative to the piston rod.
0024The piston rod can be mounted by the casing such that it can axially move back and forth. In this case, the product dosage to be delivered is set by adjusting an axially slight distance between a front end of the piston rod and the rear side of the piston by selecting the product. In this case, the piston rod forms the indicator of the drive device.
0025In some preferred embodiments, the piston rod is mounted by the casing such that it can be moved in the advancing direction but not counter to the advancing direction. In this case, movement counter to the advancing direction is at best possible in the course of exchanging the reservoir using corresponding assembly handles. In some preferred embodiments, however, restoring the piston rod is not possible. Rather, the administering apparatus is completely replaced by a new one. It would also be conceivable to divide the apparatus into a reservoir module designed as a disposable module and a dosing and drive module which can be repeatedly used with new reservoir modules. This design has already been successfully pursued in injection apparatus in the form of so-called semi-disposable injection pens and can also be advantageously used for the administering apparatus of the invention.
0026The fluid product to be administered or delivered may be a liquid for medical, therapeutic, diagnostic, pharmaceutical or cosmetic applications, or in combination for a number of these applications. The product can, for example, be insulin, a growth hormone, cortisone, collages or also liquid nutrients. In some embodiments, the administering apparatus is preferably used in applications in which a user administers the product himself/herself, as is usual in diabetes therapy. Application by trained staff only or also in the ward or outpatients field should not, however, be ruled out.
0027In the case of an injection apparatus, the product can be administered by suitable means, for example an injection cannula or a nozzle for needle-free injections. The injection can be subcutaneous, venous or intramuscular. In some embodiments, the administering apparatus can be an inhalation apparatus in which the product dosage selected or a remaining dosage still available in the reservoir is delivered from the reservoir, for example, into a chamber of the inhalation apparatus, and atomized by means of a vaporizer or other atomizing means, for inhalation. Furthermore, taking the product orally or administering the product via a feeding tube is also conceivable, to name but a few examples of administering.
BRIEF DESCRIPTION OF THE DRAWINGS
0028<figref idref="DRAWINGS">FIG. 1</figref> depicts an injection apparatus in a longitudinal section;
0029<figref idref="DRAWINGS">FIG. 2</figref> depicts the rear part of the injection apparatus;
0030<figref idref="DRAWINGS">FIG. 3</figref> depicts the injection apparatus in a cross-section;
0031<figref idref="DRAWINGS">FIG. 4</figref> depicts a dosing member of the injection apparatus in a longitudinal section;
0032<figref idref="DRAWINGS">FIG. 5</figref> depicts a modified dosing member in a longitudinal section;
0033<figref idref="DRAWINGS">FIG. 6</figref> depicts the rear part of the injection apparatus in a minimum-dosage state and “not loaded”;
0034<figref idref="DRAWINGS">FIG. 7</figref> depicts the rear part of the injection apparatus in a maximum-dosage state and “not loaded”;
0035<figref idref="DRAWINGS">FIG. 8</figref> depicts the rear part of the injection apparatus in a maximum-dosage state and “loaded”;
0036<figref idref="DRAWINGS">FIG. 9</figref> depicts a view onto a dosage display in the apparatus state in <figref idref="DRAWINGS">FIG. 6</figref>;
0037<figref idref="DRAWINGS">FIG. 10</figref> depicts the view onto a dosage display after a “loading process” from the state in <figref idref="DRAWINGS">FIG. 9</figref>;
0038<figref idref="DRAWINGS">FIG. 11</figref> depicts the view onto a dosage display in the apparatus state in <figref idref="DRAWINGS">FIG. 7</figref>;
0039<figref idref="DRAWINGS">FIG. 12</figref> depicts the view onto a dosage display in the apparatus state in <figref idref="DRAWINGS">FIG. 8</figref>; and
0040<figref idref="DRAWINGS">FIG. 13</figref> depicts a dosage scale, unwound onto the plane of the page.
DETAILED DESCRIPTION
0041<figref idref="DRAWINGS">FIG. 1</figref> shows a complete longitudinal section of an injection apparatus. It is a gear rack pen for self-administering, for example, insulin or growth hormones. A first, front casing section <b>1</b> and a second, rear casing section <b>3</b> form a casing of the pen. The casing sections <b>1</b> and <b>3</b> are sleeve bodies. To form the casing, they are plugged into each other along a common central longitudinal axis L, in a non-releasable connection. Furthermore, the connection is such that the casing sections <b>1</b> and <b>3</b> cannot be moved relative to each other, either axially or rotationally about the longitudinal axis L.
0042An ampoule <b>2</b> accommodated in the front casing section <b>1</b> forms a reservoir for a product which is administered by way of injection using the pen. An outlet of the ampoule <b>2</b> is sealed by a membrane. An injection needle N is however guided through the membrane and protrudes via a rear end into the ampoule <b>2</b>. A piston K is accommodated at a rear end of the ampoule <b>2</b> facing away from the outlet. An axial movement of the piston K along the longitudinal axis L in an advancing direction pointing towards the ampoule outlet delivers product from the ampoule <b>2</b> and through the injection needle N, thus administering it. In the state shown, the front casing section <b>1</b> is covered by an outer protective cap P and the injection needle N, still separate, is covered by an inner protective cap which of course has to be removed before administering.
0043The rear casing section <b>3</b> forms a mechanism holder by mounting a piston rod <b>8</b> acting on the piston K in the advancing direction and the other components of the pen, which participate in selecting a product dosage to be delivered and delivering the product dosage selected. These other components are a drive member <b>10</b> and an operating element <b>18</b> which together form a drive device <b>37</b> for the piston rod <b>8</b>, and furthermore a dosing member <b>35</b> which in cooperation with the rear casing section <b>3</b> serves to select the product dosage to be delivered from the ampoule <b>2</b>.
0044In <figref idref="DRAWINGS">FIG. 2</figref>, these components and their couplings are shown enlarged. Reference may also always be additionally made to the cross-sectional representation in <figref idref="DRAWINGS">FIG. 3</figref>. On the outer surface of the piston rod <b>8</b>, four rows of teeth <b>9</b> formed from serrated teeth extend in the longitudinal direction, each offset by 90° with respect to each other. The rows of teeth <b>9</b> each exhibit the same separation. Each of the rows of teeth <b>9</b> is offset by a quarter pitch with respect to each of the other rows of teeth <b>9</b>, in order to improve the dosing precision in a way known in its own right.
0045The rear casing section <b>3</b> forms blocking elements <b>4</b> which engage with the rows of teeth <b>9</b>. The piston rod <b>8</b> is blocked by the engagement of the blocking elements <b>4</b>, such that it is not possible to move the piston rod <b>8</b> counter to the advancing direction of the piston K. Movement of the piston rod <b>8</b> in the advancing direction, however, is permitted.
0046In order to advance the piston rod <b>8</b>, the drive device <b>37</b> engages with the rows of teeth <b>9</b> of the piston rod <b>8</b> via slaving means <b>11</b>, behind the blocking elements <b>4</b>. The drive device <b>37</b> is formed by the sleeve-shaped drive member <b>10</b> and the sleeved-shaped operating element <b>18</b>. The operating element <b>18</b> is pushed from behind onto the drive member <b>10</b>. The connection between the drive member <b>10</b> and the operating element <b>18</b> is such that the operating element <b>18</b> cannot be axially moved relative to the drive member <b>10</b>, but can be rotated about the longitudinal axis L relative to the drive member <b>10</b>. The longitudinal axis L forms a translational axis of the drive device <b>37</b> and the driven device K, <b>8</b> consisting of the piston K and the piston rod <b>8</b>, and furthermore, a rotational axis of the operating element <b>8</b>.
0047The drive device <b>37</b> viewed as a whole protrudes through the dosing member <b>35</b>. The slaving means <b>11</b> of the drive member <b>10</b> can be bent free, in particular free from the dosing member <b>35</b>, elastically outwards from the mesh, in the radial direction, in order to enable the drive device <b>37</b> to move relative to the piston rod <b>8</b> counter to the advancing direction. The slaving means <b>11</b> are formed in a section of the drive device <b>37</b> protruding forwards out of the dosing member <b>35</b>; in the example embodiment, they form the front end of the drive device <b>37</b>. The engagement of the slaving means <b>11</b> and the shape of the rows of teeth <b>9</b> are such that the piston rod <b>8</b> is necessarily slaved by a movement of the drive device <b>37</b> in a drive direction directed towards the piston K, said drive direction being identical to the advancing direction.
0048In the depicts exemplary embodiment, the rows of teeth <b>9</b> are pointed in the advancing direction in a shape of serrated teeth. In modified embodiments, however, the piston rod <b>8</b> could comprise, instead of one or more rows of teeth <b>9</b>, recesses or other engaging means for slaving means of a drive device, if it is only ensured that piston rod <b>8</b> is necessarily slaved in the advancing direction but is prevented from being slaved counter to the advancing direction.
0049The dosing member <b>35</b> is formed by a sleeve-shaped inner dosing body <b>13</b> and a sleeve-shaped outer dosing body <b>14</b>, which are produced as separate parts and immovably connected to each other. In particular, it is not possible for the two dosing bodies <b>13</b> and <b>14</b> to either axially move or rotate about the longitudinal axis L relative to each other. The outer dosing body <b>14</b> concentrically surrounds the inner dosing body <b>13</b>. A slight annular gap, into which the likewise sleeve-shaped rear casing section <b>3</b> protrudes, remains circumferential between the two dosing bodies <b>13</b> and <b>14</b>.
0050The rear casing section <b>3</b>, together with the dosing body <b>35</b>, forms a swivel joint, more precisely a screw joint, which causes a rotational movement of the dosing member <b>35</b> about the longitudinal axis L to result in a translational movement of the dosing member <b>35</b> in or counter to the advancing direction, i.e., a axial translational movement relative to the rear casing section <b>3</b>, depending on the direction of rotation. The longitudinal axis L forms a rotational axis and a translational axis of the dosing member <b>35</b>. To form the swivel joint, the rear casing section <b>3</b> and the dosing member <b>35</b> are in threaded engagement. The threaded engagement is between an inner thread <b>6</b> formed on an inner surface area of the rear casing section <b>3</b> and an outer thread <b>16</b> formed on an outer surface area of the inner dosing body <b>13</b>. Although less preferred, the threaded engagement could instead also be formed between an outer thread of the rear casing section <b>3</b> and an engaging inner thread of the outer dosing body <b>13</b>. By rotating the dosing body <b>35</b>, the user selects the product dosage to be administered. Since, through the threaded engagement, the dosing member <b>35</b> also simultaneously performs an axial translational movement, a delivery stroke of the length Ah is set for the drive device <b>37</b>, which corresponds to the product dosage selected.
0051The inner dosing body <b>13</b> forms a dosing stopper <b>15</b> which limits the movement of the drive device <b>37</b> counter to the advancing direction. More precisely, a facing area of the dosing stopper <b>15</b> pointing in the advancing direction forms the dosing stopper <b>15</b> at its front end. The dosing stopper <b>15</b> is formed by an annular collar running around the longitudinal axis L, said collar protruding radially inwards towards the drive member <b>10</b> via an inner surface area of the inner dosing body <b>13</b>. The dosing stopper <b>15</b>, more precisely its front stopper area, runs around the longitudinal axis L at an axially constant height, i.e. a linear dosing stopper <b>15</b> is formed at a single height.
0052Opposite the dosing stopper <b>15</b> in the advancing direction, the rear casing section <b>3</b> forms a delivery stopper <b>5</b> which limits the movement of the drive device <b>37</b> in the advancing direction. The drive device <b>37</b> can thus be moved in and counter to the advancing direction between the delivery stopper <b>5</b>, which is fixed to the casing and even formed by the rear casing section <b>3</b> itself, and the translationally adjustable dosing stopper <b>15</b>. The drive device <b>37</b> in turn forms a counter stopper, namely the delivery and dosing stopper <b>12</b>, on an outer surface area of the drive member <b>10</b>. The delivery and dosing stopper <b>12</b> is formed by an annular collar via a front stopper area facing the delivery stopper <b>5</b> and a rear stopper area facing the dosing stopper <b>15</b>. The delivery and dosing stopper <b>12</b> protrudes radially outwards from an outer surface area of the drive member <b>10</b> towards a facing inner surface area of the rear casing section <b>3</b>.
0053The rear casing section <b>3</b> is completely transparent or at least transparent in the section which overlaps a maximum delivery stroke of the drive device <b>37</b>. The transparency serves to verify the axial position of the drive device <b>37</b>, in particular the position of the drive member <b>10</b> which engages directly with the piston rod <b>8</b> and is rigidly connected to it via the engagement in the advancing direction.
0054For the purpose of a particularly precise optical verification, the drive member <b>10</b> is provided with a thin marking line, preferably a circumferential marking line, which is clearly visible through the rear casing section <b>3</b> and forms an indicator <b>32</b> (FIGS. <b>9</b> to <b>11</b>). Advantageously, the delivery and dosing stopper <b>12</b> itself can form the marking line by forming a thin tip, radially outwards. The delivery and dosing stopper <b>12</b> is suitable as an indicator for verifying, alone because it radially protrudes almost directly up to the rear casing section <b>3</b> or even contacts it with sliding contact. The radially outer surface area of the delivery and dosing stopper <b>12</b> or the entire, radially outer tip is preferably additionally provided with a thin marking line which is attached on the surface or in a recess on the surface or is formed in the material, and can advantageously be fluorescent.
0055As may be seen in connection with FIGS. <b>9</b> to <b>12</b>, and in particular in <figref idref="DRAWINGS">FIG. 13</figref>, the rear casing section <b>3</b> comprises a dosage scale <b>30</b> over the length of a maximum delivery stroke Ahmax. The dosage scale <b>30</b> can be attached to the inner surface area or more preferably to the outer surface area of the rear casing section <b>3</b> or let into the transparent surface of the rear casing section <b>3</b>. In the example embodiment, it is attached to the outer surface area. The dosage scale <b>30</b> is formed by dosage numbers which indicate dosage units and by dosage marks <b>31</b>. Each of the dosage numbers is each assigned to one of the dosage marks <b>31</b>. The dosage marks <b>31</b> are formed by short, thin lines which each extend in the circumferential direction of the rear casing section <b>3</b>. The dosage numbers are arranged over the circumference of the casing section <b>3</b>, ascending towards the rear, in the form of spiral around the rotational axis L of the dosing member <b>35</b>. Correspondingly, the dosage marks <b>31</b> are spirally arranged, such that each of the dosage marks <b>31</b> exhibits a different axial height to each of the other dosage marks <b>31</b>. The dosage marks <b>31</b> thus represent, in a fine axial grading, every product dosage which can be selected and delivered in whole dosage units. Due to the transparency of the rear casing section <b>3</b>, the axial position of the drive device <b>37</b> can be read, namely as the axial position which the indicator <b>32</b> of the drive device <b>37</b> assumes relative to the dosage marks <b>31</b>. In the example embodiment, the cited marking line running around the longitudinal axis L on the radially outer tip of the delivery and dosing stopper <b>12</b> forms the indicator <b>32</b> of the drive device <b>37</b>.
0056In order to make it easier to read the dosage scale <b>30</b>, in particular for people with low visual acuity, the outer dosing body <b>14</b> comprises a viewing window <b>34</b> in a surface section which overlaps the dosage scale <b>30</b>, said viewing window being developed into a magnifier <b>34</b><i>a</i>. The viewing window <b>34</b> is sufficiently large and of such a shape that precisely one of the dosage numbers of the dosage scale <b>30</b> can be identified as the dosage selected, through the viewing window <b>34</b>. In the example embodiment, it is only ever possible to read exactly one dosage number through the viewing window.
0057In order that the dosage can be selected in discrete steps corresponding to the dosage numbers of the dosage scale <b>30</b>, the dosing member <b>35</b> and the rear casing section <b>3</b> are each in releasable latching engagement in discrete rotational angular positions which the dosing member <b>35</b> can assume relative to the rear casing section <b>3</b>. The latching engagement is formed between axially extending grooves <b>7</b> and engaging members <b>17</b> which engage with the grooves <b>7</b>. In the example embodiment, the axial grooves <b>7</b> are let into the rear casing section <b>3</b> on the outer surface area. The engaging members <b>17</b> are correspondingly formed as short latching cams on the inner facing surface area of the outer dosing body <b>14</b>. The engaging members <b>17</b> are linearly guided axially in the axial grooves <b>7</b> in each of the discrete rotational angular positions of the dosing member <b>35</b>.
0058A rear end position of the dosing member <b>35</b> is defined by the engaging members <b>17</b> abutting a rear facing limiting area of the axial grooves <b>7</b>. A front end position of the dosing member <b>35</b> is defined by a rear connecting stay, which the dosing bodies <b>13</b> and <b>14</b> form between themselves, abutting against a rear facing area of the rear casing section <b>3</b>. The dosing member <b>35</b> can be adjusted back and forth, from rotational angular latching position to rotational angular latching position, between these two extreme dosing positions, in order to axially adjust the dosing stopper <b>15</b>. The maximum delivery stroke Ahmax of the drive device <b>37</b> is as large as the axial distance which the dosing stopper <b>15</b> exhibits from the delivery stopper <b>5</b> in the rear end position of the dosing member <b>35</b> minus the axial thickness of the delivery and dosing stopper <b>12</b>.
0059Although the user can at any time freely alter the product dosage set between the two extreme dosing positions, it is advantageous for most applications if a dosage, once set, no longer has to be altered. The injection apparatus can therefore be flexibly set to the needs of different users on the one hand, and used with an optimal setting for a particular user for repeatedly administering the same product dosage. In this sense, a dosage memory is also simultaneously obtained through the dosing member <b>35</b> which can be rotationally and translationally moved and therefore adjusted in combination, relative to the rear casing section <b>3</b>.
0060One advantage which should by no means be neglected is that the dimensional accuracy and simply regulation of the dimensional accuracy and the stable design of the components which are decisive for dosing and delivery are realized using very few components. This contributes to the fact that the apparatus has a simply design and not least is therefore cheap, but nonetheless operates with precision and ensures exact dosing.
0061The nested arrangement of the dosing bodies <b>13</b> and <b>14</b> is also advantageous, providing multi-functionality of the dosing member <b>35</b> despite its simple construction. For the dosing member <b>35</b> directly forms the dosing engagement with the casing of the injection apparatus, the dosing stopper <b>15</b> for the drive device <b>37</b>, a gripping part for the user and a part of a duplex dosage display, namely the display for the dosage selected on the one hand and the display for the dosage delivered on the other.
0062As a further advantage, the injection apparatus enables simple and reliable priming, i.e., bleeding the product-guiding parts between the piston K and the exit opening of the injection needle N.
0063To illustrate the priming function, reference is made to <figref idref="DRAWINGS">FIGS. 1 and 2</figref> and in particular also to <figref idref="DRAWINGS">FIGS. 3, 4</figref> and <b>5</b>. In order to fulfill the priming function, the inner dosing body <b>13</b> and the operating element <b>18</b> are engaged. The engagement consists of a guiding curve and an engaging member which engages with the guiding curve. The engaging member can be moved in a defined manner in the guiding curve between axial stoppers on the one hand and radial stoppers on the other. The guiding curve on the one hand and the engaging member on the other are formed on the mutually facing surface areas of the inner dosing body <b>13</b> and the operating element <b>18</b>.
0064As shown in <figref idref="DRAWINGS">FIGS. 3 and 4</figref>, the engaging member indicated as <b>19</b> is formed on an outer surface area of the operating element <b>18</b>, while the guiding curve indicated as <b>20</b> is let into the facing inner surface area of the inner dosing body <b>13</b>. The guiding curve <b>20</b> comprises a long axial section <b>21</b> and a contrastively short axial section <b>22</b> and a connecting section <b>24</b> which extends in the circumferential direction and connects the two axial sections <b>21</b> and <b>22</b> to each other, at their rear ends. The two side walls of the axial sections <b>21</b> and <b>22</b>, which oppose each other in the circumferential direction in the area of the connecting section <b>24</b>, form rotational stoppers <b>25</b> and <b>26</b> for the engaging member <b>19</b>. The long axial section <b>21</b> extends in the advancing direction up to the dosing stopper <b>15</b>, more precisely up to the rear facing area of the annular collar forming the dosing stopper <b>15</b>. The shorter axial section <b>22</b> runs parallel to the axial section <b>21</b> and is formed as a short blind groove. A front facing area of the axial section <b>22</b> forms a priming stopper <b>23</b>. The axial sections <b>21</b> and <b>22</b> feed onto the rear facing end of the inner dosing body <b>13</b>. The connecting section <b>24</b> is correspondingly open at the rear facing end. The engaging member <b>19</b> is formed by an axial rib formed on the outer surface of the operating element <b>18</b>. This axial rib forms the priming stopper on its free front facing area.
0065Because the engaging member <b>19</b> engages with the guiding curve <b>20</b> formed in this way, the operating element <b>18</b> can perform the shape of the movement corresponding to the guiding curve <b>20</b>, relative to the inner dosing body <b>13</b>, namely any selected delivery stroke Ah up to the maximum delivery stroke Ah<sub>max</sub>, the contrastively smaller priming stroke Ph and the rotational selecting movement. Since the operating element <b>18</b> is connected to the drive member <b>10</b> such that it cannot move axially but can rotate about the longitudinal axis L, the operating element <b>18</b> can be rotated back and forth between the rotational stoppers <b>25</b> and <b>26</b> without acting on the drive member <b>10</b>. Axial translational movement in either the long axial section <b>21</b> or the short axial section <b>22</b> is then only possible, however, together with the drive member <b>10</b>.
0066Because the connecting section <b>24</b> is arranged on the rear ends of the axial sections <b>21</b> and <b>22</b>, the rotational movement of the operating element <b>18</b> between the two rotational stoppers <b>25</b> and <b>26</b>, i.e., from the delivery position to the priming position and vice versa, is only possible when the drive member <b>10</b> is abutting the dosing stopper <b>15</b> via its delivery and dosing stopper <b>12</b>. In this “loaded” position, the engaging member <b>19</b> can be moved by rotating the operating element <b>18</b> relative to the inner dosing body <b>13</b> against the rotational stopper <b>25</b> and thus into axial flush with the priming stopper <b>23</b>. In this rotational angular position of the operating element <b>18</b>, the priming position, the drive device <b>37</b> can be moved in the advancing direction by axially pressing onto the operating element <b>18</b> up to the priming stopper <b>23</b>. The axial length Ph of this priming stroke is only a few dosing units, for example two, three or four dosing units. The axial distance between the priming stopper <b>23</b> and the priming counter stopper which forms the engaging member <b>19</b> is correspondingly short.
0067It is advantageous if the operating element <b>18</b> is in releasable latching engagement with the inner dosing body <b>13</b> flush with the axial sections <b>21</b> and <b>22</b>, i.e., on the rotational stoppers <b>25</b> and <b>26</b>, respectively. In order to obtain the latching engagement with the inner dosing body <b>13</b> in each of the delivery position and the priming position, the engaging member <b>19</b> is again provided with a thin, axial latching cam on its narrow outer surface area, said cam coming to rest in the two rotational stopper positions of the operating element <b>18</b> in each of two axial latching grooves formed correspondingly in the guiding curve <b>20</b>.
0068In the exemplary embodiment, two identical guiding curves <b>20</b> and engaging members <b>19</b> are provided which diametrically oppose each other.
0069In the variant of <figref idref="DRAWINGS">FIG. 4</figref>, the connecting section <b>24</b> runs, simply linearly, at a single axial height.
0070<figref idref="DRAWINGS">FIG. 5</figref> shows a guiding curve <b>20</b> with a connecting section <b>24</b>′ whose front guiding wall leads from the priming stopper <b>23</b> obliquely backwards into the long axial section <b>21</b>. Due to the oblique trajectory of the connecting section <b>24</b>′, a translational movement of the operating element <b>18</b>—and together with it of the drive member <b>10</b>—counter to the advancing direction and relative to the piston rod <b>8</b> is caused by a reverse rotational movement of the operating element <b>18</b> from the rotational stopper <b>25</b> towards the rotational stopper <b>26</b>. In accordance with the embodiment of a priming process, the user therefore does not have to specially retract the drive device <b>37</b> again relative to the piston rod <b>8</b>, i.e. load it. Rather, the winding or loading movement is forced by the reverse rotational movement. The guiding curve <b>20</b> in <figref idref="DRAWINGS">FIG. 5</figref> otherwise corresponds to the guiding curve <b>20</b> in <figref idref="DRAWINGS">FIG. 4</figref>.
0071The functionality of an embodiment of an injection apparatus in accordance with the present invention will now be described. <figref idref="DRAWINGS">FIGS. 6 and 9</figref> show the rear part of the injection apparatus in a longitudinal section, and each in a view in a state from which the dosage can be selected. Correspondingly, the drive device <b>37</b> abuts the delivery stopper <b>5</b>, and the dosing member <b>35</b> assumes its axially front end position. A slight distance remains between the delivery and dosing stopper <b>12</b> of the drive device <b>37</b> and the dosing stopper <b>15</b> of the dosing member <b>35</b>, said distance corresponding to two dosing units. Accordingly, the dosage of two dosage units can be read in the viewing window <b>34</b>. Furthermore, the dosage mark <b>31</b> assigned to this dosage can also clearly be seen. Since the drive device <b>37</b> abuts the delivery stopper <b>5</b> via its delivery and dosing stopper <b>12</b>, the marking line of the drive device <b>37</b> forming the indicator runs parallel to the dosage mark <b>31</b>, with an axial distance. The distance corresponds to two dosage units. This situation can be seen in <figref idref="DRAWINGS">FIG. 9</figref>. The injection apparatus is “loaded” by retracting the drive device <b>37</b>, relative to the piston rod <b>8</b>, up to the dosing stopper <b>15</b>. When this loading movement has been performed, two dosing units can be delivered by then advancing the drive device <b>37</b> and the thereby slaved piston rod <b>8</b>. <figref idref="DRAWINGS">FIG. 10</figref> shows this state, in which the drive device <b>37</b> abuts the dosing stopper <b>15</b> via its delivery and dosing stopper <b>12</b>. The dosing mark <b>31</b> assigned to the dosage number “2” and the indicator overlap each other exactly.
0072From the state shown in <figref idref="DRAWINGS">FIGS. 6 and 9</figref>, the user selects the dosage. To select the dosage, the dosing member <b>35</b> has merely to be rotated about the longitudinal axis L relative to the rear casing section <b>3</b>. Here, the outer dosing body <b>14</b> forms a gripping part and the inner dosing body <b>13</b> forms a dosing screw whose rotational movement is directly converted into the axial adjusting movement by the threaded engagement, for the purpose of selecting the dosage. The dosing is in discrete rotational angular positions which the dosing member <b>35</b> successively assumes relative to the rear casing section <b>3</b>.
0073<figref idref="DRAWINGS">FIGS. 7 and 11</figref> show the injection apparatus directly after the dosage has been selected. A dosage of <b>42</b> dosage units has been set, as can be read in the viewing window in <figref idref="DRAWINGS">FIG. 11</figref>. In the state shown in <figref idref="DRAWINGS">FIG. 7</figref>, selecting the dosage has been concluded but the injection apparatus is not yet “loaded”, for the drive device <b>37</b> is still abutting the dosing stopper <b>5</b>. This is indicated on the dosage scale <b>30</b> by the indicator <b>32</b>, as can be seen in <figref idref="DRAWINGS">FIG. 11</figref>.
0074<figref idref="DRAWINGS">FIG. 8</figref> shows maximum dosing. <figref idref="DRAWINGS">FIG. 12</figref> shows the injection apparatus in a state in which selecting the dosage has been concluded but the drive device <b>37</b> has not been retracted by the thus defined delivery stroke of length Ah, but rather only by a part of this stroke. In the state shown by way of example in <figref idref="DRAWINGS">FIG. 12</figref>, the drive device <b>37</b> has been retracted by a stroke corresponding to a product dosage of eight dosage units. This is indicated in <figref idref="DRAWINGS">FIG. 12</figref> by the axial position of the indicator <b>32</b> on the dosage scale <b>30</b>.
0075As illustrated in <figref idref="DRAWINGS">FIG. 12</figref>, a simple but reliable display of the remaining amount is obtained through the transparency of the rear casing section <b>3</b>, the form of the indicator <b>32</b> and the arrangement of the dosage scale <b>30</b>. If, namely, the ampoule no longer contains the full product dosage of, for example, 42 dosage units before the drive device <b>37</b> is retracted, then the drive device <b>37</b> can only be retracted counter to the advancing direction until the length of its next delivery stroke in the advancing direction corresponds to the product dosage still available in the ampoule <b>2</b> for a final delivery. In the exemplary embodiment, this remaining amount is eight dosage units. The indicator <b>32</b> and the dosage mark <b>31</b> assigned to the dosage of eight dosage units correspondingly overlap each other. The remaining amount which can be delivered is defined by a stopper acting between the piston rod <b>8</b> and the drive device <b>37</b>. This stopper limits the effective length of the piston rod <b>8</b>, i.e. the length by which the piston rod <b>8</b> can be moved as a whole in the advancing direction, from its position before a first delivery up until the ampoule <b>2</b> is evacuated. In the exemplary embodiment, the piston rod <b>8</b> forms this stopper for the slaving means <b>11</b> in its rear part, i.e., the slaving means <b>11</b> cannot elastically evade this stopper.
0076In the foregoing description, embodiments of the invention, including preferred embodiments, have been presented for the purpose of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise form disclosed. Obvious modifications or variations are possible in light of the above teachings. The embodiments were chosen and described to provide the best illustration of the principals of the invention and its practical application, and to enable one of ordinary skill in the art to utilize the invention in various embodiments and with various modifications as are suited to the particular use contemplated. All such modifications and variations are within the scope of the invention as determined by the appended claims when interpreted in accordance with the breadth they are fairly, legally, and equitably entitled.
Contents5
6 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US10967123B2 | Cited by | United States of America | Applicant |
| WO2014139915A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| EP3162399A1 | Cited by | European Patent Office (EPO) | Search report |
| US10881809B2 | Cited by | United States of America | Applicant |
| AU2019203244B2 | Cited by | Australia | Search report |
| EP2512559A4 | Cited by | European Patent Office (EPO) | Search report |
| US10195340B2 | Cited by | United States of America | Applicant |
| US11123494B2 | Cited by | United States of America | Applicant |
| WO2020172323A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US11007316B2 | Cited by | United States of America | Applicant |
| WO2017076927A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US11571518B2 | Cited by | United States of America | Applicant |
| EP3485929A1 | Cited by | European Patent Office (EPO) | Search report |
| US9833562B2 | Cited by | United States of America | Applicant |
| EP2512559A1 | Cited by | European Patent Office (EPO) | Search report |
| CN105188808A | Cited by | China | Search report |
| US9999732B2 | Cited by | United States of America | Applicant |
| US2001020155A1 | Cites | United States of America | Pre-grant |
| US4865591A | Cites | United States of America | Pre-grant |
| US4936833A | Cites | United States of America | Pre-grant |
| US5545147A | Cites | United States of America | Pre-grant |
| US5643214A | Cites | United States of America | Pre-grant |
| US5728074A | Cites | United States of America | Pre-grant |
| US5961495A | Cites | United States of America | Pre-grant |
| US6146361A | Cites | United States of America | Pre-grant |
| US6228067B1 | Cites | United States of America | Pre-grant |
| US6312413B1 | Cites | United States of America | Pre-grant |
| US6699224B2 | Cites | United States of America | Pre-grant |
28 members in 8 offices
Priority claims17
| Document | Office | Kind | Date |
|---|---|---|---|
| 102324107 | Germany | – | |
| 10232410 | Germany | A | |
| 10232410 | Germany | A | |
| 10232411 | Germany | A | |
| 10232411 | Germany | A | |
| 10232412 | Germany | A | |
| 10232412 | Germany | A | |
| 62197003 | United States of America | A | |
| 62197003 | United States of America | A | |
| 97033508 | United States of America | A | |
| 102324107 | – | – | – |
| 10621970 | – | – | – |
| DE2002132410 | – | – | – |
| DE2002132411 | – | – | – |
| DE2002132412 | – | – | – |
| US20030621970 | – | – | – |
| US20080970335 | – | – | – |
Members28
| Document | Office | Kind | |
|---|---|---|---|
| WO2004007000A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2004007001A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2004019333A1 | United States of America | A1 | |
| AU2003238333A1 | Australia | A1 | |
| AU2003243877A1 | Australia | A1 | |
| DE10232410A1 | Germany | A1 | |
| DE10232411A1 | Germany | A1 | |
| DE10232412A1 | Germany | A1 | |
| EP1525015A1 | European Patent Office (EPO) | A1 | |
| US2005154351A1 | United States of America | A1 | |
| EP1562660A1 | European Patent Office (EPO) | A1 | |
| CN1681548A | China | A | |
| JP2005532855A | Japan | A | |
| AU2003238333B2 | Australia | B2 | |
| EP1562660B1 | European Patent Office (EPO) | B1 | |
| AT327790T | Austria | T | |
| ATE327790T1 | Austria | T1 | |
| DE50303612D1 | Germany | D1 | |
| DE10232410B4 | Germany | B4 | |
| EP1525015B1 | European Patent Office (EPO) | B1 | |
| AT375176T | Austria | T | |
| ATE375176T1 | Austria | T1 | |
| DE50308355D1 | Germany | D1 | |
| US7316670B2 | United States of America | B2 | |
| CN100363064C | China | C | |
| US2008103435A1 | United States of America | A1 | |
| JP4263171B2 | Japan | B2 | |
| US7749200B2 | United States of America | B2 |
38 transactions on the USPTO file
Abandoned after 2 non-final rejections, 1 final rejection and 1 RCE.
- Non-final rejections
- 2
- Final rejections
- 1
- RCEs
- 1
- Appeals
- 0
Over time
Point at a mark for the transactionTransactions
| Event | Code | |
|---|---|---|
| Email NotificationEML_NTR | EML_NTR | |
| Mail Abandonment for Failure to Respond to Office ActionAbandonedMABN2 | MABN2 | |
| Aband. for Failure to Respond to O. A.AbandonedABN2 | ABN2 | |
| Electronic ReviewELC_RVW | ELC_RVW | |
| Email NotificationEML_NTF | EML_NTF | |
| Mail Non-Final RejectionNon-final rejectionMCTNF | MCTNF | |
| Non-Final RejectionNon-final rejectionCTNF | CTNF | |
| Case Docketed to Examiner in GAUDOCK | DOCK | |
| Information Disclosure Statement consideredIDSC | IDSC | |
| Reference capture on IDSRCAP | RCAP | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Date Forwarded to ExaminerFWDX | FWDX | |
| Disposal for a RCE / CPA / R129AbandonedABN9 | ABN9 | |
| Request for Continued Examination (RCE)RCEX | RCEX | |
| Request for Extension of Time - GrantedXT/G | XT/G | |
| Workflow - Request for RCE - BeginBRCE | BRCE | |
| Mail Final Rejection (PTOL - 326)Final rejectionMCTFR | MCTFR | |
| Final RejectionFinal rejectionCTFR | CTFR | |
| Date Forwarded to ExaminerFWDX | FWDX | |
| Response after Non-Final ActionA... | A... | |
| Mail Examiner Interview Summary (PTOL - 413)MEXIN | MEXIN | |
| Examiner Interview Summary Record (PTOL - 413)EXIN | EXIN | |
| Mail Non-Final RejectionNon-final rejectionMCTNF | MCTNF | |
| Non-Final RejectionNon-final rejectionCTNF | CTNF | |
| Case Docketed to Examiner in GAUDOCK | DOCK | |
| PG-Pub Issue NotificationPG-ISSUE | PG-ISSUE | |
| Information Disclosure Statement consideredIDSC | IDSC | |
| Electronic Information Disclosure StatementEIDS. | EIDS. | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| IFW TSS Processing by Tech Center CompleteTSSCOMP | TSSCOMP | |
| Application Dispatched from OIPEOIPE | OIPE | |
| Filing ReceiptFLRCPT.O | FLRCPT.O | |
| Application Is Now CompleteCOMP | COMP | |
| Sent to Classification ContractorPGPC | PGPC | |
| Cleared by OIPE CSRL194 | L194 | |
| IFW Scan & PACR Auto Security ReviewSCAN | SCAN | |
| Initial Exam Team nnIEXX | IEXX |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Information on status: application discontinuationABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTIONSTCB | STCB |
Numbers
- Publication
- 20080103435
- Publication, DOCDB
- 2008103435
- Publication, EPODOC
- US2008103435
- Application
- 11970335
- Application, DOCDB
- 97033508
- Application, EPODOC
- US20080970335
Titles
- English
- ADMINISTERING APPARATUS COMPRISING A DOSAGE DISPLAY
Classification
- CPC, 15
- A61M5/3158
- A61M5/24
- A61M5/3146
- A61M5/31536
- A61M5/31541
- A61M5/31551
- A61M5/31558
- A61M5/31561
- A61M5/31563
- A61M5/31568
- A61M5/31593
- A61M5/31595
- A61M2005/3123
- A61M2005/3125
- A61M2005/3126
- IPC, 4
- A61M5 31
- A61M5 00
- A61M5 315
- A61M5 24
- USPC, 1
- 604048000